CN103919154A - Health-care chicken sausage - Google Patents
Health-care chicken sausage Download PDFInfo
- Publication number
- CN103919154A CN103919154A CN201410170770.0A CN201410170770A CN103919154A CN 103919154 A CN103919154 A CN 103919154A CN 201410170770 A CN201410170770 A CN 201410170770A CN 103919154 A CN103919154 A CN 103919154A
- Authority
- CN
- China
- Prior art keywords
- kilogram
- chicken
- health
- dry powder
- lycopodium calvatum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 25
- 235000013580 sausages Nutrition 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 24
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 241000110637 Cuscuta chinensis Species 0.000 claims abstract description 11
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract description 11
- 244000215777 Plumeria rubra Species 0.000 claims abstract description 11
- 235000013087 Plumeria rubra Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 229920002261 Corn starch Polymers 0.000 claims abstract description 7
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 7
- 239000008120 corn starch Substances 0.000 claims abstract description 7
- 239000000049 pigment Substances 0.000 claims abstract description 7
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 7
- 235000013330 chicken meat Nutrition 0.000 claims description 29
- 241000195947 Lycopodium Species 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 19
- 230000036541 health Effects 0.000 claims description 14
- 235000018102 proteins Nutrition 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 7
- -1 0.02 kilogram Substances 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 229940099112 cornstarch Drugs 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 238000011282 treatment Methods 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 12
- 210000004072 lung Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 210000002784 stomach Anatomy 0.000 abstract description 11
- 230000007812 deficiency Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 210000002216 heart Anatomy 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000035922 thirst Effects 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 241000195954 Lycopodium clavatum Species 0.000 abstract 2
- 241000438687 Juncus roemerianus Species 0.000 abstract 1
- 229920000881 Modified starch Polymers 0.000 abstract 1
- 239000004368 Modified starch Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 235000019426 modified starch Nutrition 0.000 abstract 1
- 238000010791 quenching Methods 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 15
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 235000019713 millet Nutrition 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960004580 glibenclamide Drugs 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 201000009361 ascariasis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000020905 low-protein-diet Nutrition 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/50—Poultry products, e.g. poultry sausages
- A23L13/52—Comminuted, emulsified or processed products; Pastes; Reformed or compressed products from poultry meat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a health-care chicken sausage and relates to a health-care chicken sausage for preventing and treating hyperglycemia. The health-care chicken sausage for preventing and treating hyperglycemia is characterized by comprising the following raw materials by weight: 6-9 kg of chicken, 0.5-1.5 kg of lycopodium clavatum fluid extract dried powder, 0.2kg of salt, 0.1kg of sugar, 0.65kg of corn starch, 0.65kg of modified starch, 0.3kg of soybean protein isolate, 3kg of water, 0.03kg of color protecting pigment, 0.05kg of albumen glue, 0.02kg of essence and 0.05kg of brittleness enhancing agent. Plumeria rubra, the seed of Chinese dodder, poria cocos, tuber of dwarf lilyturf and juncus roemerianus have the effects of adjusting balance of the human five internal organs including heart, liver, spleen, lung and kidney, dispersing blood stasis, removing turbidity and quenching thirst, and lycopodium clavatum has the effects of relaxing the muscles and stimulating the blood circulation as well as tonifying qi and dredging collaterals, so that an aim of reducing blood sugar is achieved. Chicken has the effects of warming middle-Jiao and tonifying qi, tonifying deficiency and replenishing essence, strengthening the spleen and stomach and promoting blood sugar reduction, and the health-care chicken sausage is applied to prevention and treatment of hyperglycemia.
Description
Technical field
The present invention relates to a kind of health care chicken meat sausage, especially a kind of health care chicken meat sausage of preventing and treating hyperglycaemia.
Background technology
Under normal circumstances, human body can be regulated with this two large regulating system of nerve regulation and be guaranteed that the source of blood sugar and outlet keep balance, make blood sugar maintain certain level by hormone.But under the acting in conjunction of inherent cause (as diabetes family history) and environmental factor (as irrational meals, obesity etc.), two large regulatory functions get muddled, and just there will be the rising of blood sugar level.Therefore, reasonable diet can prevent and control hyperglycaemia.As for merging renal function infull diabetic, except controlling total amount of heat, should note few salt according to the state of an illness, the intake of salt-free or few sodium and protein, protein provision is unsuitable too high, and diet bean product, answer low protein diet for uremia, protein every day, staple food replaced rice, face, protein to supply with first-selected good protein with wheat starch, as milk, egg, thin pork, chicken etc. 30 grams of left and right.
The traditional Chinese medical science thinks, diabetes are mainly that the five internal organs are weak due to the plain body deficiency of Yin, multiple because of eating and drinking without temperance, overfeeding delicious food, and disorder of emotion, labor is wanted excessively, and causes deficiency of kidney-YIN, and lung stomach is scorching; Interpretation of the cause, onset and process of an illness emphasis is that the deficiency of Yin is scorching, and taking the deficiency of Yin as this, scorching is mark; With the passing of time disease prolongs, yin deficiency affecting yang, deficiency in both YIN and YANG; The deficiency of Yin is scorching, and the bright liquid in consumption Tianjin makes blood viscous, the not smooth stasis of blood that forms of blood; Yin deficiency affecting yang, the deficiency of yang is cold solidifying, also can cause sun in hemostasis.
Motherland's medical science thinks, chicken has effect of Wen Zhongyi gas, qi-restoratives replenishing essence, strengthening the spleen and stomach, the arteries and veins of invigorating blood circulation, strengthening the bones and muscles.Chicken to malnutritive, chilly is afraid of cold, weak fatigue, irregular menstruation, anaemia, weakness etc. have good dietary function.
Prior art is not applied lycopodium calvatum preparation and prevents and treats the health care chicken meat sausage of hyperglycaemia, and the single and health care of taste has its limitation.As invention---the preparation method of millet chicken sausage that is 200710058582.9 at the number of patent application of Chinese patent information centre announcement, this disclosure of the invention a kind of preparation method of millet chicken sausage, solve the problems such as the bowel lavage based food existing in prior art is higher fatty acid, high cholesterol, comprised the raw material of following part by weight: the millet of chicken, chicken weight 15～30%, step is, dry-salt chicken, to millet pretreatment, cut and mix, bowel lavage exhaust, baking, boiling etc.; Product surface is dry, and glossy, tangent plane is creamy white, color and luster uniformity; The compound fragranced with chicken, millet, fresh perfume (or spice) is good to eat, free from extraneous odour; Structural state is tight, and tangent plane is smooth, smooth, is rich in epistasis, and content is in conjunction with even; This invention health care has its advantage, but also has weak point.
Summary of the invention
In order to solve prior art problem, the object of the invention is to provide a kind of health care chicken meat sausage of preventing and treating hyperglycaemia.
Technical scheme: a kind of health care chicken meat sausage of preventing and treating hyperglycaemia, comprises the raw material of following weight: chicken 6-9 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, 0.2 kilogram of salt, 0.1 kilogram of sugar, 0.65 kilogram of cornstarch, 0.65 kilogram of converted starch, 0.3 kilogram of soybean protein isolate, 3 kilograms, water, protect 0.03 kilogram of pigment, 0.05 kilogram of protein adhesive, 0.02 kilogram, essence, increase crisp dose 0.05 kilogram; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: 1, first chicken is put into meat grinder and rub into meat stuffing, then other batching and water are mixed thoroughly, pour in meat stuffing and mix pasty state, pickle 2-4 hour, enter sausage filler; 2. sausage filler is inserted in in casing one end and records, record full, mono-of every 20CM, button is beaten at two; 3. cold water is cooked, after boiling little fiery boiling 20 minutes ripe, take out air-dry.
As optimization, a kind of health care chicken meat sausage of preventing and treating hyperglycaemia of the present invention, comprises the raw material of following weight: chicken 6-9 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, 0.2 kilogram of salt, 0.1 kilogram of sugar, 0.65 kilogram of cornstarch, 0.65 kilogram of converted starch, 0.3 kilogram of soybean protein isolate, 3 kilograms, water, protect 0.03 kilogram of pigment, 0.05 kilogram of protein adhesive, 0.02 kilogram, essence, increase crisp dose 0.05 kilogram; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Lycopodium calvatum, toil temperature, expelling wind and clearing away cold, dehumidifying are subsided a swelling, are stimulated the circulation of the blood and cause the muscles and joints to relax." Hunan medicine will " records lycopodium calvatum: sweet, flat.Nontoxic, enter the heart, kidney two warps, relax the muscles and stimulate the blood circulation, invigorating qi and dredging collateral.
Frangipanis, cool in nature, taste is sweet, light; Return large intestine, stomach warp, there is effect of moistening lung removing toxic substances, clearing heat and expelling damp, laxation.
Radix Glycyrrhizae taste is sweet, flat.The thoughts of returning home, lung, spleen, stomach warp.Function cures mainly: invigorates the spleen and benefits qi, and clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, the anxious pain of four limbs contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Seed of Chinese dodder acrid-sweet flavor, property is flat, enters liver, kidney two warps.There is tonifying kidney and benefiting sperm, nourish the liver to improve visual acuity, antiabortive effect.
Poria cocos taste is sweet, light, property is flat, be used as medicine there is clearing damp and promoting diuresis, the function of beneficial spleen and stomach, antitoxic heart-soothing and sedative.Modern medicine study: Poria cocos energy enhanced machine body immunity function, pachymaran has significantly antitumor and protect the liver dirty effect.
The tuber of dwarf lilyturf, the micro-sugariness hardship of property, cold, there is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, reinforcing yin essence benefit essence, five viscera settling effect.
Rush, is slightly cold; Sweet, light; The thoughts of returning home; Lung; Small intestine; Urinary bladder channel.Effect: promoting diuresis for stranguria; Clearing heart fire.Dark plum acid, puckery, flat, returns liver, spleen, lung, large intestine channel.[function cures mainly] astringes the lung, and puckery intestines, promote the production of body fluid, claming ascaris.For chronic cough of deficiency lung, protracted dysentery laxation, abnormal heat is quenched one's thirst, ascariasis of biliary tract vomiting stomachache, ascariasis of biliary tract (" Chinese pharmacopoeia ").
Advantage of the present invention: 1, lycopodium calvatum Xin Wenyi impairment of yin blood of the present invention, therefore adapted frangipanis, Radix Glycyrrhizae are in harmonious proportion, make its institute partially, its taste is glycol, fresh and sweet, has channels sootheing and network vessel quickening, function of promoting blood circulation to disperse blood clots.
2, seed of Chinese dodder tonifying kidney and benefiting sperm, Poria cocos clearing damp and promoting diuresis, beneficial spleen and stomach, the tuber of dwarf lilyturf is nourishing Yin and moistening lung, reinforcing stomach reg fluid, the relieving restlessness that clears away heart-fire, and rush clearing heart fire, dark plum are quenched one's thirst and are brought down a fever, and more contribute to promoting blood circulation and removing blood stasis hypoglycemic.
3, the present invention is by the balance of frangipanis, the seed of Chinese dodder, Poria cocos, the tuber of dwarf lilyturf, rush conditioning human body-centered liver spleen lung kidney the five internal organs, stagnation resolvation is pure and impure quenches one's thirst, relax the muscles and stimulate the blood circulation with lycopodium calvatum again, thereby invigorating qi and dredging collateral reaches hypoglycemic object, promote blood sugar decreasing effect by chicken Wen Zhongyi gas, qi-restoratives replenishing essence, strengthening the spleen and stomach, be applicable to prevention and control hyperglycaemia.
4, Chinese medicine powder of the present invention has significant hypoglycemic activity to adrenaline hyperglycaemia mouse and alloxan hyperglycemia mouse.Each 20 of male and female mice is selected in experiment; Adopt respectively adrenaline and alloxan to set up hyperglycaemia mouse model, then give Chinese medicine powder of the present invention, glibenclamide, insoral and treat and survey blood sugar level.In the hyperglycemia mouse of bringing out at adrenaline, Chinese medicine powder of the present invention can make fasting serum glucose [(16. 58 ± 3. 92) mmol/L] be reduced to (7. 56 ± 2. 63) mmol/L, effect and glibenclamide comparison, no significant difference (P>0.05); In the hyperglycemia mouse of model induced by alloxan, the present invention is reduced to fasting serum glucose [(15. 56 ± 1. 83) mmol/L] (7. 55 ± 1.65) mmol/L, blood sugar reducing function is significantly better than insoral (P<0 05), and causes hypoglycemic side effect without glibenclamide.Conclusion: the present invention can significantly reduce the blood sugar level (P <0. 001) of 2 kinds of modeling animals, and makes blood sugar be down to normal level.
5, Chinese medicine powder of the present invention shows through more than the 60 routine sugared dung patients' that make a definite diagnosis clinical observation on the therapeutic effect, and the present invention has remarkable reduction glycosuria patient's blood sugar level, makes blood sugar recovery normal.
Clinical observation result of the present invention:
1.1 physical data: select the People's Hospital of city outpatient service diabetes B patient 60 examples, be divided at random two groups.Treatment group 30 examples, male 16 examples, female's 14 examples, 30～70 years old age, average (50 ± 1.5) year, the course of disease 6 months～15 years, average (8.0 ± 1.2) year; Control group 30 examples, male 18 examples, female's 12 examples, 29～70 years old age.Two groups of physical data comparing difference not statistically significants (P>0.05), have comparativity.
1.2 case selections: with reference to the World Health Organization's (WHO) diabetes diagnosis in 1999 and somatotype standard [1]: diabetic symptom+random time plasma glucose levels >=11.1mmol/L(200mg/dl).The patient's random packet that meets above-mentioned standard is carried out to observational study, and the patient that part takes traditional Chinese medicine stops former Chinese medicine and includes observation in after 2 weeks, and the patient's to be directly brought into not taking traditional Chinese medicine is observed.Two groups of patients all give diabetes Primary Care, comprise diet control, kinesiatrics and orally-taken blood sugar reducing Western medicine, and hypoglycemic Western medicine adopts melbine, carries out drug usage and dose adjustment according to blood sugar situation.
1.3 methods of treatments: treatment group is taken Chinese medicine powder of the present invention on the basis of taking melbine.Basic side is made up of the composition of raw materials of following weight portion: lycopodium calvatum 10, frangipanis 10, Radix Glycyrrhizae 3, the seed of Chinese dodder 5, Poria cocos 10, the tuber of dwarf lilyturf 5; Every natural gift are taken for three times, each 4 grams.Control group routine is taken melbine.Two groups are consistent in diet control, kinesiatrics, and be 2 months two groups of courses for the treatment of.
1.4 observation index: measure respectively fasting blood-glucose (FPG), postprandial blood sugar (2hBG), glycosylated hemoglobin (HbA1c), FPI (FINS), blood fat (TC, TG, HDL-C, LDL-C) before and after treatment, blood sugar determination of glucose oxidase, insulin is measured with putting the method for exempting from, blood fat is measured with automatic clinical chemistry analyzer, HOMA-IR employing Haffner etc. [3,4] in Homa model, calculate the formula of IR, be HOMA-IR=FPG × FINS/22.5 (FPG unit is mmol/L, and FINS unit is mU/L).
1.5 statistical methods: adopt SPSS 14.0 statistical analysis softwares to carry out statistical procedures.Measurement data adopts t inspection, enumeration data chi-square criterion.
2 results: before and after two groups of treatments, the variation of FPG, 2hBG, HbAIc, FINS and HOMA-IR refers to table 1.By in table 1, we can see, treat front two groups of patient FPG, 2hBG, HbAlc, FINS, the horizontal comparing difference not statistically significant of HOMA-IR (P>0.05); After treating, two groups of FPG, 2hBG, HbAlc, FINS, HOMA-IR levels have statistical significance (P<0.05 or P<0.01) with the front comparing differences for the treatment of, before treatment group patient's These parameters and treatment, relatively have significant difference (P<0.01).Prompting treatment group and control group all can reduce diabetes blood sugar, but it is more obvious to improve blood sugar with treatment group.
The variation of FPG, 2hBG, HbAlc, FINS and HOMA-IR before and after table 1 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; The rear two groups of FINS for the treatment of and HOMA-IR compare ^P<0.05, ^^P<0.01.
Before and after two groups of patient treatments, the variation of TC, TG, HDL-C, LDL-C is in table 2.From table 2, we can see the front two groups of patients' for the treatment of the horizontal comparing difference not statistically significant of TC, TG, HDL-C, LDL-C (P>0.05); After treatment, TC, TG, HDL-C, the LDL-C level of two groups have significant change, wherein TC, TG, LDL-C level have statistical significance (P<0.05) with the front comparing difference for the treatment of, and relatively have significant difference (P<0.01) before treatment group HDL-C level and treatment.Illustrate that treatment group and control group all can improve diabetic's blood lipid level, and more remarkable with treatment group effect.
The variation of TC, TG, HDL-C, the horizontal content of LDL-C before and after table 2 liang group patient treatment
Note: indices is compared with before treatment: * P<0.05, * * P<0.01; After treatment, two groups of indices are compared ^P<0.05, ^^P<0.01.
Detailed description of the invention
Embodiment 1: a kind of health care chicken meat sausage of preventing and treating hyperglycaemia, comprises the raw material of following weight: chicken 6-9 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, 0.2 kilogram of salt, 0.1 kilogram of sugar, 0.65 kilogram of cornstarch, 0.65 kilogram of converted starch, 0.3 kilogram of soybean protein isolate, 3 kilograms, water, protect 0.03 kilogram of pigment, 0.05 kilogram of protein adhesive, 0.02 kilogram, essence, increase crisp dose 0.05 kilogram; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
Preparation method: 1, first chicken is put into meat grinder and rub into meat stuffing, then other batching and water are mixed thoroughly, pour in meat stuffing and mix pasty state, pickle 2-4 hour, enter sausage filler; 2. sausage filler is inserted in in casing one end and records, record full, mono-of every 20CM, button is beaten at two; 3. cold water is cooked, after boiling little fiery boiling 20 minutes ripe, take out air-dry.
Embodiment 2: a kind of health care chicken meat sausage of preventing and treating hyperglycaemia, comprises the raw material of following weight: chicken 6-9 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, 0.2 kilogram of salt, 0.1 kilogram of sugar, 0.65 kilogram of cornstarch, 0.65 kilogram of converted starch, 0.3 kilogram of soybean protein isolate, 3 kilograms, water, protect 0.03 kilogram of pigment, 0.05 kilogram of protein adhesive, 0.02 kilogram, essence, increase crisp dose 0.05 kilogram; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Preparation method is with embodiment 1.
Claims (2)
1. prevent and treat a health care chicken meat sausage for hyperglycaemia, it is characterized in that comprising the raw material of following weight: chicken 6-9 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, 0.2 kilogram of salt, 0.1 kilogram of sugar, 0.65 kilogram of cornstarch, 0.65 kilogram of converted starch, 0.3 kilogram of soybean protein isolate, 3 kilograms, water, protect 0.03 kilogram of pigment, 0.05 kilogram of protein adhesive, 0.02 kilogram, essence, increase crisp dose 0.05 kilogram; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10.
2. prevent and treat a health care chicken meat sausage for hyperglycaemia, it is characterized in that comprising the raw material of following weight: chicken 6-9 kilogram, 0.5-1.5 kilogram, lycopodium calvatum liquid extract dry powder, 0.2 kilogram of salt, 0.1 kilogram of sugar, 0.65 kilogram of cornstarch, 0.65 kilogram of converted starch, 0.3 kilogram of soybean protein isolate, 3 kilograms, water, protect 0.03 kilogram of pigment, 0.05 kilogram of protein adhesive, 0.02 kilogram, essence, increase crisp dose 0.05 kilogram; Described lycopodium calvatum liquid extract dry powder is made after liquid extract freeze drying again by the composition of raw materials of following weight portion and is ground into dry powder: lycopodium calvatum 10-20, frangipanis 8-20, Radix Glycyrrhizae 3-10, seed of Chinese dodder 5-10, Poria cocos 10-20, tuber of dwarf lilyturf 5-10, rush 3-5, dark plum 3-10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410170770.0A CN103919154A (en) | 2014-04-27 | 2014-04-27 | Health-care chicken sausage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410170770.0A CN103919154A (en) | 2014-04-27 | 2014-04-27 | Health-care chicken sausage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103919154A true CN103919154A (en) | 2014-07-16 |
Family
ID=51137738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410170770.0A Pending CN103919154A (en) | 2014-04-27 | 2014-04-27 | Health-care chicken sausage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103919154A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104522710A (en) * | 2014-12-23 | 2015-04-22 | 廖彬佳 | Chicken sausage for preventing and treating tumor |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1302618A (en) * | 2000-01-06 | 2001-07-11 | 张川大 | Process for preparing medicine to treat diabetes |
| CN101138369A (en) * | 2006-09-06 | 2008-03-12 | 蔡如桂 | Thirst-eliminating tea |
| CN102940268A (en) * | 2012-11-29 | 2013-02-27 | 陈花娇 | Chicken sausage |
| CN102940256A (en) * | 2012-11-29 | 2013-02-27 | 陈花娇 | Goose sausage |
-
2014
- 2014-04-27 CN CN201410170770.0A patent/CN103919154A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1302618A (en) * | 2000-01-06 | 2001-07-11 | 张川大 | Process for preparing medicine to treat diabetes |
| CN101138369A (en) * | 2006-09-06 | 2008-03-12 | 蔡如桂 | Thirst-eliminating tea |
| CN102940268A (en) * | 2012-11-29 | 2013-02-27 | 陈花娇 | Chicken sausage |
| CN102940256A (en) * | 2012-11-29 | 2013-02-27 | 陈花娇 | Goose sausage |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104522710A (en) * | 2014-12-23 | 2015-04-22 | 廖彬佳 | Chicken sausage for preventing and treating tumor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103689378A (en) | Burdock functional fine dried noodles and preparation method thereof | |
| CN103919153A (en) | Healthcare quail sausage | |
| CN103907957A (en) | Bamboo rat sausage | |
| CN103919176A (en) | Lobster meat sausage | |
| CN103919022A (en) | Health-care steamed buns for preventing and treating hyperglycemia | |
| CN103919155A (en) | Healthcare pigeon sausage | |
| CN102150779B (en) | Health food for regulating and stabilizing blood sugar and preparation method thereof | |
| CN103947925A (en) | Buckwheat porridge | |
| CN103932226A (en) | Venison sausage | |
| CN103919162A (en) | Mutton sausage | |
| CN103919154A (en) | Health-care chicken sausage | |
| CN103907963A (en) | Crocodile meat sausage | |
| CN103919175A (en) | Prawn sausage | |
| CN103907951A (en) | Health-care duck meat sausage | |
| CN103907952A (en) | Health-care ostrich meat sausage | |
| CN103907956A (en) | Health horsemeat sausage | |
| CN103931996A (en) | Health-care goose meat sausage | |
| CN103907970A (en) | Whitebait meat balls | |
| CN105707538A (en) | Nutrient vermicelli suitable for women | |
| CN103947916A (en) | Jelly | |
| CN103931999A (en) | Beef sausage | |
| CN103931772A (en) | Milk tea | |
| CN103919161A (en) | Healthcare pork sausage | |
| CN103919163A (en) | Ass meat sausage | |
| CN103918740A (en) | Premixed powder for preventing and treating hyperglycemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140716 |